BlackRock Investment Management, LLC - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 165 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$8,304,000
-9.4%
667,499
-0.3%
0.01%
-9.1%
Q3 2016$9,168,000
+86.6%
669,672
+0.7%
0.01%
+83.3%
Q2 2016$4,913,000
+30.7%
664,847
+13.0%
0.01%
+20.0%
Q1 2016$3,759,000
+6.7%
588,332
+4.4%
0.01%0.0%
Q4 2015$3,522,000
+7.3%
563,474
+0.3%
0.01%
+25.0%
Q3 2015$3,281,000
-30.1%
561,742
-1.1%
0.00%
-33.3%
Q2 2015$4,697,000
+25.0%
567,997
+24.5%
0.01%
+20.0%
Q1 2015$3,759,000
+21.9%
456,151
+1.6%
0.01%
+25.0%
Q4 2014$3,084,000
+25.9%
448,920
-1.0%
0.00%
+33.3%
Q3 2014$2,449,000
-14.8%
453,585
+0.5%
0.00%
-25.0%
Q2 2014$2,875,000
+473.9%
451,299
+626.4%
0.00%
+300.0%
Q1 2014$501,000
+16.5%
62,127
-1.4%
0.00%0.0%
Q4 2013$430,000
-86.2%
63,037
-62.7%
0.00%
-80.0%
Q3 2013$3,106,000
+132.3%
168,791
+120.8%
0.01%
+150.0%
Q2 2013$1,337,00076,4340.00%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$82,111,00018.09%
Consonance Capital Management LP 5,575,742$35,629,0005.39%
Opaleye Management Inc. 1,250,000$7,988,0004.98%
Tamarack Advisers, LP 1,600,000$10,224,0003.58%
Camber Capital Management LP 5,405,235$34,539,0002.02%
IRONWOOD INVESTMENT MANAGEMENT LLC 324,636$2,074,0001.36%
Palo Alto Investors LP 2,248,317$14,367,0001.12%
1492 Capital Management LLC 202,500$1,294,0001.09%
Geduld E E 120,100$767,0001.05%
JS Capital Management LLC 868,700$5,551,0001.00%
View complete list of ARIAD PHARMACEUTICALS INC shareholders